Jadhav HR - Search Results

1

Medicinal chemistry-based perspectives on thiophene and its derivatives: exploring structural insights to discover plausible druggable leads.

Thakur S, Kumar D, Jaiswal S, Goel KK, Rawat P, Srivastava V, Dhiman S, Jadhav HR, Dwivedi AR. Thakur S, et al. Among authors: jadhav hr. RSC Med Chem. 2024 Oct 30. doi: 10.1039/d4md00450g. Online ahead of print. RSC Med Chem. 2024. PMID: 39601022 Free PMC article. Review.

2

A perspective on the development of small molecular neprilysin inhibitors (NEPi) with emphasis on cardiorenal disease.

Thakur S, Mohanty P, Jadhav MS, Gaikwad AB, Jadhav HR. Thakur S, et al. Among authors: jadhav hr. Eur J Med Chem. 2024 Dec 15;280:116932. doi: 10.1016/j.ejmech.2024.116932. Epub 2024 Oct 4. Eur J Med Chem. 2024. PMID: 39378824 Review.

3

Design, synthesis, in silico, and in vitro evaluation of pyrrol-2-yl-phenyl allylidene hydrazine carboximidamide derivatives as AChE/BACE 1 dual inhibitors.

Sharma A, Rudrawar S, Sharma A, Bharate SB, Jadhav HR. Sharma A, et al. Among authors: jadhav hr. RSC Adv. 2024 Aug 23;14(37):26703-26722. doi: 10.1039/d4ra03589e. eCollection 2024 Aug 22. RSC Adv. 2024. PMID: 39184009 Free PMC article.

4

Unveiling the potential of novel indol-3-yl-phenyl allylidene hydrazine carboximidamide derivatives as AChE/BACE 1 dual inhibitors: a combined in silico, synthesis and in vitro study.

Sharma A, Rudrawar S, Sharma A, Bharate SB, Jadhav HR. Sharma A, et al. Among authors: jadhav hr. RSC Adv. 2024 Jul 30;14(33):23853-23872. doi: 10.1039/d4ra04315d. eCollection 2024 Jul 26. RSC Adv. 2024. PMID: 39081657 Free PMC article.

5

A structure-based pharmacophore modelling approach to identify and design new neprilysin (NEP) inhibitors: An in silico-based investigation.

Thakur S, Sinhari A, Gaikwad AB, Jadhav HR. Thakur S, et al. Among authors: jadhav hr. Arch Biochem Biophys. 2024 Jun;756:110019. doi: 10.1016/j.abb.2024.110019. Epub 2024 Apr 28. Arch Biochem Biophys. 2024. PMID: 38688397

6

Network pharmacology combined with molecular docking and dynamics to assess the synergism of esculetin and phloretin against acute kidney injury-diabetes comorbidity.

Dagar N, Jadhav HR, Gaikwad AB. Dagar N, et al. Among authors: jadhav hr. Mol Divers. 2024 Apr 5. doi: 10.1007/s11030-024-10829-5. Online ahead of print. Mol Divers. 2024. PMID: 38578376

7

Renoprotective effect of esculetin against ischemic acute kidney injury-diabetic comorbidity.

Dagar N, Habshi T, Shelke V, Jadhav HR, Gaikwad AB. Dagar N, et al. Among authors: jadhav hr. Free Radic Res. 2024 Feb;58(2):69-87. doi: 10.1080/10715762.2024.2313738. Epub 2024 Feb 12. Free Radic Res. 2024. PMID: 38323807

8

Bioactivity predictions and virtual screening using machine learning predictive model.

Siddiqui NF, Vishwakarma P, Thakur S, Jadhav HR. Siddiqui NF, et al. Among authors: jadhav hr. J Biomol Struct Dyn. 2024 Jan 12:1-20. doi: 10.1080/07391102.2023.2300132. Online ahead of print. J Biomol Struct Dyn. 2024. PMID: 38217308

9

Targeting the epigenetic reader "BET" as a therapeutic strategy for cancer.

Wahi A, Manchanda N, Jain P, Jadhav HR. Wahi A, et al. Among authors: jadhav hr. Bioorg Chem. 2023 Nov;140:106833. doi: 10.1016/j.bioorg.2023.106833. Epub 2023 Sep 4. Bioorg Chem. 2023. PMID: 37683545 Review.

10

Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents.

Wahi A, Jain P, Sinhari A, Jadhav HR. Wahi A, et al. Among authors: jadhav hr. Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):675-702. doi: 10.1007/s00210-023-02674-4. Epub 2023 Aug 24. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 37615708 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters